Fairman RM, Velazquez O, Carpenter JP, Baum RA, Golden MA, Mitchell M, Pyeron A, Criado F, Barker CF: The complicated aortic neck is not a contraindication to successful endovascular repair. Journal of Vascular Surgery 2003.
Fairman RM, Hunt JL, Mohler ER, Mitchell ME, Carpenter JP, Scoll B, Wolfe E, Neschis DG, Velazquez OC, Cusak A, Golden MA: Bone formation and neovascularization in carotid plaques: A clinicopathologic correlation. Journal of Vascular Surgery 2003.
Golden MA: Detection of arterial bypass graft threatening lesion. [Invited Commentary] Journal of Vascular Surgery 2003.
Golden MA, Hanna AK: Modification of vein graft adaptation using adenoviral vectors. New Advances in Vascular Biology and Molecular and Cardiovascular Medicine 2003.
Larson RA, Golden MA: The biology of restenosis and intimal hyperplasia. Vascular Surgery: Principles and Practice, Third Edition. Hobson RW II (eds.). St. Louis: Mosby, Page: 325-40, 2003.
Baum RA, Carpenter JP, Golden MA, Velazquez OC, Clark, TW, Stavropoulous SW, Cope C, Fairman RM: Treatment of type 2 endoleaks after endovascular repair of abdominal aortic aneurysms: Comparison of transarterial and translumbar techniques. Journal of Vascular Surgery 35(1): 23-29, Jan 2002.
Carpenter JP, Baum RA, Barker CF, Golden MA, Velazquez OC, Mitchell ME, Fairman RM: Durability of benefits of endovascular versus conventional abdominal aortic aneurysm repair. Journal of Vascular Surgery 35(2): 222-228, Feb 2002.
Murciano JC, Harshaw D, Neschis DG, Koniaris L, Bdeir K, Medinilla S, Fisher AB, Golden MA, Cines DB, Nakada MT, Muzykantov VR: Platelets inhibit the lysis of pulmonary microemboli. American Journal of Physiology - Lung Cell Molecular Physiology 282(3): L529-539, Mar 2002.
Fairman RM, Carpenter JP, Baum RA, Larson RA, Golden MA, Barker CF, Mitchell ME, Velazquez OC: Potential impact of therapeutic warfarin treatment on type II endoleaks and sac shrinkage rates on midterm follow-up examination. Journal of Vascular Surgery 35(4): 679-85, Apr 2002.
Meneveau NF, Klugherz BD, Chaqour B, Anand V, Tomaszewski JE, Joullie MM, Macarak E, Golden MA, Weisz PB, Wilensky RL: Beta cyclodextrin tetradecasulfate, a novel cyclic oligo-saccharide, inhibits thrombus and neointimal formation after coronary vascular injury. Coronary Artery Disease 13(3): 189-97, May 2002.
back to top
Last updated: 05/26/2009
The Trustees of the University of Pennsylvania